Dr. Chris Karapetis
Claim this profileFlinders Medical Centre
Studies Tumors
Studies Anxiety Disorders
5 reported clinical trials
9 drugs studied
Area of expertise
1Tumors
Stage IV
2Anxiety Disorders
Stage III
Stage II
Clinical Trials Chris Karapetis is currently running
APG-115 + Pembrolizumab
for Skin Cancer
This study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of APG-115, an MDM2 inhibitor, either alone or in combination with pembrolizumab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of the immune response concomitant to inhibition of the MDM2 pathway (which restores p53 functions) may promote cancer cell death, leading to effective anticancer therapy.
Recruiting1 award Phase 1 & 213 criteria
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
More about Chris Karapetis
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Chris Karapetis has experience with
- Physical Activity Program
- Health Education Materials
- APL-101
- Cisplatin/Gemcitabine
- Futibatinib
- Regorafenib
Breakdown of trials Chris Karapetis has run
Anxiety Disorders
Colorectal Cancer
Sleep Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chris Karapetis specialize in?
Chris Karapetis focuses on Tumors and Anxiety Disorders. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are undergoing treatment.
Is Chris Karapetis currently recruiting for clinical trials?
Yes, Chris Karapetis is currently recruiting for 2 clinical trials in Bedford Park South Australia. If you're interested in participating, you should apply.
Are there any treatments that Chris Karapetis has studied deeply?
Yes, Chris Karapetis has studied treatments such as Physical Activity Program, Health Education Materials, APL-101.
What is the best way to schedule an appointment with Chris Karapetis?
Apply for one of the trials that Chris Karapetis is conducting.
What is the office address of Chris Karapetis?
The office of Chris Karapetis is located at: Flinders Medical Centre, Bedford Park, South Australia 5042 Australia. This is the address for their practice at the Flinders Medical Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.